ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA~PAI-1 and tPA~PAI-1)
| Autor: | Peter A. Andreasen, Anneke Geurts, N. Grebenschikov, Fred C.G.J. Sweep, J. J. T. M. Heuvel, Hans De Witte, Theo Benraad, Susanne L. Schousboe |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Urokinase
chemistry.chemical_classification Cancer Research Serial dilution biology Molecular biology Tissue plasminogen activator law.invention chemistry.chemical_compound Enzyme Oncology Biochemistry chemistry law Polyclonal antibodies Development of assays for prognostic factors in oncological endocrinology Plasminogen activator inhibitor-1 Ontwikkeling van meetmethodes voor prognostische factoren in de oncologische endocrinologie medicine biology.protein Recombinant DNA Antibody medicine.drug |
| Zdroj: | International Journal of Cancer, 81, 598-606 International Journal of Cancer, 81, pp. 598-606 Grebentschikov, N, Sweep, F, Geurts, A, Andreasen, P, de Witte, H, Schousboe, S L, Heuvel, J & Benraad, T 1999, ' ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1) ', International Journal of Cancer, vol. 81, pp. 598-606 . |
| ISSN: | 0020-7136 |
| Popis: | An ELISA has been developed for the assessment of complexes between the urokinase-type (uPA) and the tissue-type plasminogen (tPA) activators with their inhibitor type-1 (PAI-1) in cell-culture medium and cytosolic extracts of breast tumours. The "4-stage/2-site" ELISA involves 2 polyclonal antibodies in the pre-analyte stage 2 and in the post-analyte stage. For the specific measurement of the uPA-PAI-1 complex, 2 assay formats may be employed, uPA/PAI-1 and PAI-1/uPA. This offers an attractive facility for quality-assessment studies of this kind of assays. Analogously, the tPA-PAI-1 complex was assessed using the formats tPA/PAI-1 and PAI-1/tPA. Only complexes are able to evoke a signal in their appropriate assay formats. The free component, however, which responds to the capture antibody, could interfere with the binding of the complex molecule, reducing the OD signal. Increasing the coating Ab concentration diminishes the signal-suppressing effect of the free component. In 15 cell-culture supernatants, uPA and PAI-1 concentrations were measured as well as the uPA of PAI-1 complex in different dilutions in 2 assay formats. The differences between the values of complex measured in the 2 assay formats could be accounted for by the free uPA and PAI-1 concentrations. At dilution 1:10, the measured values obtained in the 2 separate formats differed substantially (correlation coefficient r = 0.641). At dilution 1:20, the differences were already smaller between the values (agreement 0.945). At dilution 1:30, close agreement between the corresponding values was observed (r = 0.971). Extrapolation to infinite dilution of the results obtained resulted in an even closer estimation of the complex concentration. Comparable results have been observed when tPA, PAI-1 and tPA-PAI-1 values were measured in tumour biopsy extracts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text